HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback